Previous studies have reported that miR-99a can inhibit mTOR expression by directly targeting its 3′-UTR in numerous human cancers including prostate cancer cells, childhood adrenocortical tumor cells, and c-Src-transformed cells[12], [17], [24]. This evidence concerns the gene MTOR and prostate cancer.